Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH)
April 25, 2019 Off

Gilead Announces Topline Data From Phase 3 STELLAR-3 Study of Selonsertib in Bridging Fibrosis (F3) Due to Nonalcoholic Steatohepatitis (NASH)

By BusinessWire

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-3, a Phase 3, randomized, double-blind, placebo-controlled study evaluating…

April 25, 2019 Off

Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…

April 25, 2019 Off

BioLabs@NYULangone Welcomes MEND as Newest Resident

By BusinessWire

–Award-winning startup selected to join state-of-the-art coworking facility– NEW YORK–(BUSINESS WIRE)–BioLabs@NYULangone today announced that MEND, a company developing nutritional interventions…

April 25, 2019 Off

IQVIA’s OCE Technology Platform Selected by Salehiya Medical to Enhance Customer Experience in Saudi Arabia

By BusinessWire

Building customer trust and loyalty through more effective engagement DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA™ (NYSE:IQV) today announced…

April 25, 2019 Off

Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers

By BusinessWire

— Peer-Reviewed Publication Details Next Steps for Access to Safe, Secure DNA Synthesis — SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience…

April 25, 2019 Off

Rainier Therapeutics Announces Vofatamab Data Accepted for Presentation at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

By BusinessWire

-FIERCE-21 and FIERCE-22 Phase 2 Trials in Metastatic Bladder Cancer- SAN LEANDRO, Calif.–(BUSINESS WIRE)–Rainier Therapeutics, Inc., a privately-held clinical stage…

April 25, 2019 Off

EnClear Therapies is First Place Winner of Massachusetts Medical Device Development Center $200K Challenge

By BusinessWire

— EnClear Wins Massachusetts Life Sciences Center Award — CAMBRIDGE, Mass.–(BUSINESS WIRE)–EnClear Therapies, a biotechnology company developing device-based therapies for…

April 25, 2019 Off

CoreBiome Announces Leading Microbiome Researcher Rob Knight as Scientific Advisor

By BusinessWire

ST. PAUL, Minn.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/microbiome?src=hash" target="_blank"gt;#microbiomelt;/agt;–CoreBiome, a microbiome discovery services provider and wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR),…

The Medicines Company Reports First-Quarter 2019 Financial Results and Significant Progress with the Inclisiran Clinical Development Program
April 25, 2019 Off

The Medicines Company Reports First-Quarter 2019 Financial Results and Significant Progress with the Inclisiran Clinical Development Program

By BusinessWire

Inclisiran’s unique profile, vast global market opportunity and long-dated exclusivity set the stage for potentially significant shareholder value creation Independent…

Novaliq and BLP Management Group Established New Company, Betaliq Inc., to Leverage EyeSol Technology to Treat Glaucoma
April 25, 2019 Off

Novaliq and BLP Management Group Established New Company, Betaliq Inc., to Leverage EyeSol Technology to Treat Glaucoma

By BusinessWire

Said Barry Butler, “I believe the advantages offered by theEyesol® platform will bring significant benefits to glaucomapatients.”

Posts pagination

Previous 1 … 3,251 3,252 3,253 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine